Results 201 to 210 of about 101,810 (380)

Building a Better Innovation System: Combining Facially Neutral Patent Standards withTherapeutics Regulation [PDF]

, 2008
Rai, Arti K.
core   +1 more source

Pharmacovigilance of Biopharmaceuticals in Rheumatic Diseases, Adverse Events, Evolution, and Perspective: An Overview

, 2020
Sandra Rodríguez, A. Muñoz, Rosa‐Helena Bustos, Diego Jaimes   +3 more
openalex   +1 more source

L‐Relationship between uncertainty and average seizure frequency in clinical trials of antiseizure medications

Epilepsia, EarlyView.
Abstract Objective Antiseizure medications are approved based on clinical trials that demonstrate their efficacy as measured by reductions in seizure frequency (SF). When designing these trials, trialists must select inclusion criteria where SF can be reliably measured to maintain statistical power.
Wesley T. Kerr, Neo Kok, Katherine N. McFarlane, Advith S. Reddy, Lavanya Biju, Jacqueline A. French, Daniel M. Goldenholz   +6 more
wiley   +1 more source

Impact of National Drug Price Negotiation policy on the innovation performance of biopharmaceutical industry in China. [PDF]

Front Public Health
Zhu Y, Zhu J, Gao X, Sun Y, Yan H, Du W, Wang Y, Li X.   +7 more
europepmc   +1 more source

Epileptic drop attacks: More than just atonic seizures

Epilepsia Open, EarlyView.
Abstract “Drop attacks” are not officially defined by the International League Against Epilepsy. Seizures are characterized by a sudden loss of control over the trunk and posture, leading to falls and injuries, and resolving within a few seconds. Accurately diagnosing the type of seizure is usually difficult due to limitations in clinical documentation
Tomonori Ono, Kazuaki Sato, Ryoko Honda, Hiroshi Otsubo   +3 more
wiley   +1 more source

Feasibility analysis of automated cleaning in biopharmaceutical production using cleaning-in-place concepts from food production. [PDF]

Front Med Technol
Groten F, Henze C, Joppa M, Herbst L, Nießing B, Mauermann M, Schmitt RH.   +6 more
europepmc   +1 more source

Development path and capital structure of belgian biotechnology firms [PDF]

This study investigates the relationship between the evolution of real options values and associated financing policies for Belgian companies in the sector of bio-industries.
Albert Corhay, Georges Hübner, Pierre-Armand Michel, Véronique Bastin   +3 more
core  

Automated Determination of Major and Trace Metals in Biopharmaceutical Samples of Complex Matrix Using Seafast Preparation System Coupled to Inductively Coupled Plasma Mass Spectrometry

Qiang Tu, Wendy Zhong
openalex   +1 more source

A History of Biopharmaceutics in the Food and Drug Administration 1968–1993 [PDF]

, 2009
Jerome P. Skelly
openalex   +1 more source

Perinatal Gut Dysbiosis Reduces Milk Oligosaccharides via LPS‐Mediated Gut–Mammary Signaling in Mice

Food Frontiers, EarlyView.
Maternal gut dysbiosis elevates Gram‐negative bacterial lipopolysaccharide (LPS), which enters circulation and accumulates in mammary tissue. This compromises the blood–milk barrier and suppresses key enzymatic genes, ultimately reducing milk oligosaccharide synthesis and potentially affecting neonatal gut microbiota through breastfeeding.
Man‐Lin Zhou, Ye Wang, Yan‐Ling Kang, Bushra Walayat, Bin‐Qi Rui, Qi‐Di Xue, Xi He, Jing‐Yu Yan, Yin‐Hui Liu, Ming Li   +9 more
wiley   +1 more source